Oxford Biomedica plc (LON:OXB)
London · Delayed Price · Currency is GBP · Price in GBX 606.00
+13.00 (2.19%)
At close: Mar 25, 2026
Oxford Biomedica Market Cap
Oxford Biomedica has a market cap or net worth of 732.49 million as of March 25, 2026. Its market cap has increased by 146.41% in one year.
Market Cap
732.49M
Enterprise Value
784.04M
Revenue
151.21M
Ranking
n/a
PE Ratio
n/a
Stock Price
606.00
Market Cap Chart
Since September 22, 1997, Oxford Biomedica's market cap has increased from 17.39M to 732.49M, an increase of 4,111.25%. That is a compound annual growth rate of 14.01%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 25, 2026 | 732.49M | -1.51% |
| Dec 31, 2025 | 743.72M | 67.15% |
| Dec 31, 2024 | 444.94M | 108.92% |
| Dec 29, 2023 | 212.97M | -50.00% |
| Dec 30, 2022 | 425.96M | -59.79% |
| Dec 31, 2021 | 1.06B | 24.98% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Genus | 1.70B |
| Oxford Nanopore Technologies | 1.12B |
| Avacta Group | 290.87M |
| PureTech Health | 277.10M |
| Scancell Holdings | 119.34M |
| 4basebio | 78.93M |
| Bioventix | 73.67M |
| Hemogenyx Pharmaceuticals | 66.82M |